On the evening of August 24, Aier Ophthalmology released the semi-annual report for 2018. During the reporting period, the total operating income was 377,981,300 yuan, an increase of 45.94% over the same period of the previous year. The net profit attributable to shareholders of listed companies was 502,065,700 yuan. The year-on-year growth was 40.61%, and the net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses increased by 44.50% over the same period of the previous year.
Aier Ophthalmology's main business is to operate a national chain of specialized ophthalmology hospitals, mainly engaged in various types of ophthalmology diseases, surgical services and medical optometry, is the world's leading ophthalmic medical chain, the world's largest ophthalmology group, IPO Listed medical institutions.
Outpatient and surgical volume decreased due to factors such as consolidation, but the overall revenue of Aier Ophthalmology continued to increase. In the first half of 2018, the number of eye clinics in Aier was 2,744,100, a year-on-year increase of 21.97%; the number of operations was 280,000, an increase of 20.43%; the growth rate of outpatient and surgical volume decreased by 3.93% and 4.06% respectively compared with the same period of last year. Aier Ophthalmology achieved operating income of RMB 3,788.1134 million in the first half of the year, a year-on-year increase of 45.94%, and an increase of 10.02% over the same period last year. Although the growth rate of outpatient volume and surgical volume was slightly lower than that of the same period of last year, the growth of Aier Ophthalmology's income side showed a significant increase. It shows that the consumption upgrading trend is significant, and the proportion of high-end business and customer unit price are higher. fast.
Benefiting from the national consumption upgrade, Reuters business revenue continues to grow explosively, and the growth potential of optometry business is very large, and the overall income of Aier Ophthalmology will continue to increase rapidly in the future. In the first half of 2018, the company achieved a revenue of 1.465 billion yuan, a year-on-year increase of 84.11%. The income from cataract surgery was 764 million yuan, a year-on-year increase of 17.13%. The income from anterior segment surgery was 432 million yuan, a year-on-year increase of 16.77. %, the operation of the posterior segment of the eye achieved a revenue of 275 million yuan, a year-on-year increase of +24.06%, and the income of optometry services reached 640 million yuan, a year-on-year increase of 28.50%. The income of Aier Ophthalmology Refractive Business achieved rapid growth compared with the same period of last year, mainly due to the rapid growth of refractive surgery, the increase in the proportion of high-end surgery such as full femtosecond and ICL, the trend of increasing volume and price, and the contribution of European CB. As a result, it has led to a rapid increase in the overall income of Aier Ophthalmology.
Mature hospitals still achieve 20% year-on-year growth. European CB ophthalmology operations exceeded expectations, and new hospitals and sub-new hospitals have a large growth rate. According to some hospital operating data disclosed in the report, it is predicted that the income and profit of the top 8 mature hospitals of Aier Ophthalmology will achieve 19.8% and 20.7% year-on-year growth respectively. Last year, the European CB ophthalmology profit of 54 million yuan in the past year and its 2016 total The business results in the fiscal year were equal; the actual profit contribution of 8 mature hospitals and 5 partner hospitals and European CB disclosed by Aier Ophthalmology was excluded, and the remaining 66 hospitals represented by the new and new hospitals achieved 52% year-on-year growth. In the first half of 2018, it accounted for 37% of the total profit of Aier Ophthalmology, and there is still room for growth in relatively mature hospitals.
Aier Ophthalmology attaches great importance to the construction of science and education research platform and personnel training, and perfects the medium and long-term incentive mechanism. Aier Ophthalmology has always attached importance to the construction of science and education research platform and personnel training, and improved the rapid chain replication and expansion of medium and long-term incentive mechanism. .
In terms of talent pool. Aier Ophthalmology actively promotes the integration of medical education and research, and has established a training system covering various subspecialties in ophthalmology. Because Aier has many complicated cases, the cultivation efficiency is high, and the talents grow naturally. It is understood that Aier Ophthalmology launched the “Partner Program†in the medical industry in 2014, aiming to change the ecological environment in which ophthalmologists practice and maximize the creativity and initiative of the core backbone. This is the first “Partners Program†in China's medical industry. Excellent ophthalmologists and management talents can join together as a partner shareholder and Aier Ophthalmology to invest in eye hospitals and start a business together to enjoy the high growth of ophthalmology. More than 30,000 Chinese doctors, Aier Ophthalmology accounted for more than 3,000, and may be higher in the future. Many technologies were first introduced by Aier Ophthalmology, and then other eye hospitals in China followed. In response, the spokesperson said, "Chinese ophthalmology has been shortened by at least five years in line with international standards due to the emergence of Aier Ophthalmology." In addition, Aier Ophthalmology has gradually increased its investment in scientific research and academics, thereby enhancing the brand in the industry and attracting doctors to join. Create a larger talent team.
Editor's comment : Aier's ophthalmology report exceeded expectations, it is not difficult to see that Aier Ophthalmology's development vision is very broad, behind it is its unique external expansion and development model. This is due to the strong chain expansion capability of Aier Ophthalmology. Aer Eye can not only establish a joint venture hospital with local state-owned hospitals, but also choose a suitable private hospital for acquisition. Finally, you can choose to build a new hospital.
Further encourage and guide social capital to organize medical institutions, support social forces to provide multi-level diversified medical services and relax clinic approval restrictions... With the launch of these national-level initiatives, it has laid a loose environment for the future development of Aier Ophthalmology. It is foreseeable that with the participation of more partners and the unique development model of Aier Ophthalmology, more partner eye hospitals will serve more ophthalmological patients in need in the future and continue to advance the process of smart medical care in China.
Glutinous rice is the hulled rice of glutinous rice, which is mainly produced in southern my country. It is rich in nutrients and contains protein, fat, sugar, calcium, phosphorus, iron, vitamin B1, vitamin B2, niacin and starch. It is a warm tonic and strong food, and has a certain relief effect on poor appetite, abdominal distension and diarrhea. It has the effects of relieving frequent urination, invigorating the spleen and warming the stomach, and invigorating the middle and benefiting qi. At the same time, glutinous rice is sticky and difficult to digest. After eating too many greasy dishes, you should avoid eating a lot of glutinous rice.
Jilin Yomi Agricultural and Sideline Products Import and Export Co.LTD. focusing on building a green base, building a characteristic industrial chain, deepening the channel supply chain, vigorously developing export trade, and leading the development direction of the entire industry; insisting on green development, promoting the concept of health, and making every effort to build a national leading enterprise in the organic grain industry.
Sticky Rice,Sticky Rice Gluten Free,Sticky Rice Nutrition,Thai Sticky Rice
Yomifresh , https://www.yomifresh.com